干眼症治疗市场：依产品类型、通路和地区划分

据估计，2026年干眼症治疗市场规模为132.9亿美元，预计2033年将达到384.2亿美元。预计2026年至2033年，该市场将以16.4%的复合年增长率成长。

干眼症（DES），也称为干燥性角膜疾病或角膜干燥症，是一种常见疾病，当泪液无法充分润滑眼球时就会发生。干眼症患者可能出现眼表损伤、泪膜不稳定和视力障碍。泪膜覆盖眼球表面，由三层交织的物质组成。最外层的脂质层由睑板腺分泌，有助于防止泪液蒸发并使泪液均匀分布。中间的浓稠水层由泪腺分泌，最内层的亲水性黏蛋白层则由结膜杯状细胞和眼表上皮细胞分泌。干眼症的病因众多，可分为原发性和续发性。干眼症的发生可能由多种因素引起，包括发炎性疾病（血管性、过敏性等）、环境因素（过敏原、香烟烟雾、干燥气候等）、荷尔蒙失衡（例如闭经妇女或接受荷尔蒙补充疗法的患者）以及配戴隐形眼镜。其他干眼症的原因还包括某些疾病，例如类风湿性关节炎、修格兰氏症候群、甲状腺疾病、红斑性狼疮、睑缘炎（眼睑炎肿胀和发红）、睑内翻（眼睑向内翻转）、睑外翻（眼睑向外翻转）以及暴露于烟雾、风或非常干燥的气候中。

市场动态

新的干眼症治疗方法不断涌现，许多新药也等候核准审批。强大的产品平臺蕴藏着巨大的成长机会，预计在预测期内，多个在研发线产品的核准将推动市场成长。例如，2021年10月，专注于眼科疾病治疗方法研发和商业化的生物製药公司Oyster Point Pharma宣布，其0.03毫克盐酸伐Varenicline鼻喷雾TYRVAYA已获得美国食品药物管理局（FDA）核准，用于治疗干眼症的症状和体征。 TYRVAYA鼻喷雾是一种选择性胆碱能促效剂，可激活基础泪液分泌，每日两次，每次向每个鼻孔鼻喷雾。

本研究的主要特点：

• 本报告对全球干眼症治疗市场进行了详细分析，以 2021 年为基准年，给出了预测期（2022-2030 年）的市场规模和復合年增长率。
• 本报告指出了各个细分市场的潜在商机，并说明了该市场中具有吸引力的投资提案矩阵。
• 此外，本研究还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域展望以及主要企业采取的竞争策略的重要见解。
• 本报告根据以下参数对全球干眼症治疗市场的主要参与者进行了分析：公司概况、产品系列、主要亮点、财务表现和策略。
• 透过利用本报告中提出的见解，企业行销负责人和经营团队将能够就未来的产品发布、产品升级、市场扩张和行销策略做出明智的决策。
• 这份全球干眼症治疗市场报告的目标受众包括投资者、供应商、产品製造商、经销商、新参与企业和金融分析师等产业相关人员。
• 透过对全球干眼症治疗市场进行分析时所使用的各种策略矩阵，相关人员将能够更轻鬆地做出决策。

目录

第一章：研究目标与前提条件

• 研究目标
• 前提
• 简称

第二章 市场范围

• 报告摘要
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章：市场动态、监管与趋势分析

• 市场动态
  • 促进因素
  • 阻碍因素
  • 市场机会
• 影响分析
• 市场趋势
• 近期趋势
• 企业合併情景
• 技术概述
• 法规环境
• PEST分析
• 波特的分析

第四章：全球干眼症治疗市场：依产品类型划分（2026-2033 年）

• 概述
• Cyclosporine
• 口服类固醇
• 人工泪液
• 欧米伽补充剂
• 泪囊
• 其他的

第五章：全球干眼症治疗市场：依通路划分（2026-2033 年）

• 概述
• 医院药房
• 零售药房
• 超级市场/大卖场
• 网路药房

第六章：全球干眼症治疗市场：按地区划分（2026-2033 年）

• 北美洲
  • 我们
  • 加拿大
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
• 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韩国
  • 其他亚太地区
• 中东
  • GCC
  • 以色列
  • 其他中东国家
• 非洲
  • 北非
  • 中非
  • 南非

第七章 竞争情势

• AbbVie Inc.
• Novartis AG
• Bausch Health Companies Inc.
• Johnson &Johnson, Inc.
• I-MED Pharma inc.
• Santen Pharmaceutical Co., Ltd
• AFT Pharmaceuticals
• Novaliq GmbH
• Otsuka Pharmaceutical Co., Ltd.
• Sun Pharmaceutical Industries, Inc.
• Teva Pharmaceutical Industries Ltd.
• Mitotech, SA
• Viatris Inc.

Dry Eye Syndrome Treatment Market is estimated to be valued at USD 13,290 Mn in 2026 and is expected to reach USD 38,420 Mn by 2033, growing at a compound annual growth rate (CAGR) of 16.4% from 2026 to 2033.

Dry eye syndrome (DES) is also known as keratisis sicca and keratoconjunctivitis sicca. Dry eye disease is a common condition that occurs when your tears aren't able to provide adequate lubrication for your eyes. Patients suffering from DES show damage to the ocular surface, instability in the tear film, and visual disturbance. Tear film covers the ocular surface which is made up of three intertwined layers, a superficial lipid layer produced by meibomian glands assist in reducing tear evaporation and uniform tear spreading, middle thick aqueous layer produced from lacrimal glands, and the innermost hydrophilic mucin layer produced from goblet cells of conjunctiva and epithelium of ocular surface. Dry eye syndrome is associated with a long list of causes which can be divided into primary and secondary. Dry eye may develop secondary to inflammatory disease (e.g. vascular, allergic), environmental conditions (e.g. allergens, cigarette smoke, dry climate), hormonal imbalance (e.g. perimenopausal women and patients under hormone replacement therapy), and contact lens wear. Other causes of dry eye are certain diseases, such as rheumatoid arthritis, Sjogren's syndrome, thyroid disease, and lupus Blepharitis (when eyelids are swollen or red), Entropion (when eyelids turn in), ectropion (eyelids turn outward) and being in smoke, wind or a very dry climate.

Market Dynamics

New dry eye therapies are introduced in the market with several new medications in the pipeline seeking approval. Strong product pipeline offers great market growth opportunity as approval of numerous pipeline products is expected to drive the market growth during the forecast period. For instance, in October 2021, Oyster Point Pharma, Inc., a biopharmaceutical company focused on the discovery, development and commercialization of therapies to address ophthalmic disease, announce the U.S. Food and Drug Administration (FDA) approval for TYRVAYA (varenicline solution) Nasal Spray 0.03 mg, for the treatment of the signs and symptoms of dry eye disease. YRVAYA Nasal Spray is a selective cholinergic agonist delivered twice daily as an aqueous nasal spray into each nostril to activate basal tear production.

Key features of the study:

• This report provides in-depth analysis of the global dry eye syndrome treatment market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global dry eye syndrome treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include AbbVie Inc., Novartis AG, Bausch Health Companies Inc., Johnson & Johnson, Inc., I-MED Pharma inc., Santen Pharmaceutical Co., Ltd, AFT Pharmaceuticals, Novaliq GmbH, Otsuka Pharmaceutical Co., Ltd., Sun Pharmaceutical Industries, Inc., Teva Pharmaceutical Industries Ltd., Mitotech, SA, Viatris Inc., among other prominent players
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global dry eye syndrome treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global dry eye syndrome treatment market

Market Segmentation

• Product Type Insights (Revenue, USD Mn, 2026 - 2033)
  • Cyclosporine
  • Oral Corticosteroid
  • Artificial Tears
  • Omega Supplements
  • Punctual Bags
  • Other
• Distribution Channel Insights (Revenue, USD Mn, 2026 - 2033)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Supermarket/ Hypermarket
  • Online Pharmacies
• Regional Insights (Revenue, USD Mn, 2026 - 2033)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • AbbVie Inc.
  • Novartis AG
  • Bausch Health Companies Inc.
  • Johnson & Johnson, Inc.
  • I-MED Pharma inc.
  • Santen Pharmaceutical Co., Ltd
  • AFT Pharmaceuticals
  • Novaliq GmbH
  • Otsuka Pharmaceutical Co., Ltd.
  • Sun Pharmaceutical Industries, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Mitotech, SA
  • Viatris Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product Type
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Market Trends
• Recent Developments
• Acquisitions and Partnerships Scenario
• Technology Overview
• Regulatory Scenario
• PEST Analysis
• Porter's Analysis

4. Global Dry Eye Syndrome Treatment Market, By Product Type, 2026-2033, (USD Mn)

• Overview
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Cyclosporine
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Oral Corticosteroid
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Artificial Tears
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Omega Supplements
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Punctual Bags
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Others
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends

5. Global Dry Eye Syndrome Treatment Market, By Distribution Channel, 2026-2033, (USD Mn)

• Overview
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Hospital Pharmacies
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Retail Pharmacies
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Supermarket/ Hypermarket
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Online Pharmacies
  • Market Share Analysis, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends

6. Global Dry Eye Syndrome Treatment Market, By Region, 2026-2033, (USD Mn)

• Introduction
  • Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
  • Y-o-Y Growth Analysis, For Region, 2021 - 2033
• North America
  • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
  • Y-o-Y Growth Analysis, For Country, 2021 - 2033
  • Market Size and Forecast, By Product Type, 2026-2033, (USD Mn)
  • Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026-2033, (USD Mn)
    • U.S.
    • Canada
• Latin America
  • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
  • Y-o-Y Growth Analysis, For Country, 2021 - 2033
  • Market Size and Forecast, By Product Type, 2026-2033, (USD Mn)
  • Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026-2033, (USD Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
  • Y-o-Y Growth Analysis, For Country, 2021 - 2033
  • Market Size and Forecast, By Product Type, 2026-2033, (USD Mn)
  • Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026-2033, (USD Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
  • Y-o-Y Growth Analysis, For Country, 2021 - 2033
  • Market Size and Forecast, By Product Type, 2026-2033, (USD Mn)
  • Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026-2033, (USD Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
  • Y-o-Y Growth Analysis, For Country, 2021 - 2033
  • Market Size and Forecast, By Product Type, 2026-2033, (USD Mn)
  • Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026-2033, (USD Mn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
  • Y-o-Y Growth Analysis, For Country, 2021 - 2033
  • Market Size and Forecast, By Product Type, 2026-2033, (USD Mn)
  • Market Size and Forecast, By Distribution Channel, 2026-2033, (USD Mn)
  • Market Size and Forecast, By Country, 2026-2033, (USD Mn)
    • North Africa
    • Central Africa
    • South Africa

7. Competitive Landscape

• AbbVie Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Novartis AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Bausch Health Companies Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Johnson & Johnson, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• I-MED Pharma inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Santen Pharmaceutical Co., Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• AFT Pharmaceuticals
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Novaliq GmbH
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Otsuka Pharmaceutical Co., Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Sun Pharmaceutical Industries, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Teva Pharmaceutical Industries Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Mitotech, SA
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Viatris Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies